n-n--bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine-n-n--diacetic-acid and Brain-Neoplasms

n-n--bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine-n-n--diacetic-acid has been researched along with Brain-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for n-n--bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine-n-n--diacetic-acid and Brain-Neoplasms

ArticleYear
Subacute Stroke Mimicking Cerebral Metastasis in 68Ga-PSMA-HBED-CC PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:10

    A 65-year-old man with disseminated bone metastases of prostate cancer was referred for Ga-PSMA-HBED-CC-PET/CT (short PSMA-PET/CT) to exclude visceral metastases before treatment of bone metastases with Ra-dichloride. Apart from disseminated bone metastases, PSMA-PET/CT revealed a focal cerebral tracer uptake in the right frontal lobe highly suspicious for cerebral spread. According to patient history, a cerebral infarction occurred 14 days before PSMA imaging in corresponding localization confirmed by MRI scanning. This case demonstrates the possibility of false-positive finding of cerebral metastases in PSMA-PET early after stroke.

    Topics: Aged; Antigens, Surface; Brain Neoplasms; Diagnosis, Differential; Edetic Acid; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Stroke

2016